What is the Keytruda patent cliff facing Merck? It refers to the approaching loss of exclusivity on Keytruda, the ...
The Oilers must select a full-time emergency backup goaltender who travels and practices with the team under the NHL’s new ...
FDA IND clearance enables phase 1/2a evaluation of Bria-PROS+ in advanced prostate cancer under a “study may proceed” letter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results